Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Therapies

Cancer Therapies

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Evaluation of whole blood immunoreactivity].

Khirurgiia·2024

Same author

Taxonomic composition and biodiversity of the gut microbiome from patients with irritable bowel syndrome, ulcerative colitis, and asthma.

Vavilovskii zhurnal genetiki i selektsii·2022

Same author

[Abnormal development of the hard palate revealed during the forensic examination of bone remains].

Sudebno-meditsinskaia ekspertiza·2021

Same author

[Death of Pyotr Stolypin: forensic medical aspects].

Sudebno-meditsinskaia ekspertiza·2020

Same author

[Acute complications of gastrointestinal stromal tumors].

Khirurgiia·2020

Same author

Granulocyte colony-stimulating factor downregulates interferon-gamma receptor expression and stimulates interleukin-6 production in activated human macrophages.

Growth factors (Chur, Switzerland)·2019

Search research articles

Related Experiment Video

Updated: Mar 29, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Multiple-purpose immunotherapy for cancer.

V I Seledtsov¹, A G Goncharov¹, G V Seledtsova²

¹lmmanuel Kant Baltic Federal University, 3 Botkin str., 236016 Kaliningrad, Russia.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie

|December 15, 2015

Summary

Whole tumor cell vaccines show promise for cancer immunotherapy by targeting multiple tumor-associated antigens (TAAs). Combining these vaccines with other therapies may significantly improve patient outcomes.

Keywords:

Antitumor immunoprotection Cancer cell-based vaccines Combined immunotherapy Immunosuppression

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Related Experiment Videos

Last Updated: Mar 29, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Area of Science:

Immunology
Oncology
Vaccine Development

Background:

Anti-cancer vaccination is a key strategy for inducing antitumor immune responses and overcoming tumor-induced immunosuppression.
Whole tumor cells or lysates are more effective cancer vaccines than individual tumor-associated antigens (TAAs) due to their ability to target multiple TAAs.
Cancer cell-based vaccines can be autologous, allogeneic, or xenogeneic, with xenogeneic vaccines offering advantages in breaking immune tolerance.

Purpose of the Study:

To explore the potential of whole tumor cell-based cancer vaccines.
To highlight the benefits of xenogeneic vaccines in overcoming immune tolerance.
To propose combination strategies for enhanced cancer immunotherapy.

Main Methods:

Utilizing whole tumor cells or lysates as the basis for cancer vaccines.
Investigating autologous, allogeneic, and xenogeneic vaccine approaches.
Considering the integration of immunostimulating and immunosuppression-blocking modalities.

Main Results:

Whole tumor cell vaccines can elicit immune responses against multiple TAAs.
Xenogeneic vaccines demonstrate efficacy in breaking pre-existing immune tolerance to TAAs.
Combination therapies involving vaccination show potential for improved clinical outcomes.

Conclusions:

Whole tumor cell-based vaccines are a promising approach in cancer immunotherapy.
Combining cancer vaccines with other immunotherapeutic strategies is likely to enhance clinical efficacy.
Future research should focus on optimizing these combination protocols for improved patient outcomes.